These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8432455)
1. Quantification of disease activity in Crohn's disease by computer analysis of Tc-99m hexamethyl propylene amine oxime (HMPAO) labelled leucocyte images. Giaffer MH; Tindale WB; Senior S; Barber DC; Holdsworth CD Gut; 1993 Jan; 34(1):68-74. PubMed ID: 8432455 [TBL] [Abstract][Full Text] [Related]
2. Background subtraction: a new approach to the assessment of disease activity in Crohn's disease using 99mTc-HMPAO-labelled leucocytes. Giaffer MH; Tindale WB; Holdsworth CD Scand J Gastroenterol Suppl; 1994; 203():55-60. PubMed ID: 7973451 [TBL] [Abstract][Full Text] [Related]
3. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease. Giaffer MH; Tindale WB; Holdsworth D Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940 [TBL] [Abstract][Full Text] [Related]
4. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance. Sciarretta G; Furno A; Mazzoni M; Basile C; Malaguti P Gut; 1993 Oct; 34(10):1364-9. PubMed ID: 8244102 [TBL] [Abstract][Full Text] [Related]
5. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Schölmerich J; Schmidt E; Schümichen C; Billmann P; Schmidt H; Gerok W Gastroenterology; 1988 Nov; 95(5):1287-93. PubMed ID: 3169496 [TBL] [Abstract][Full Text] [Related]
6. [Scintigraphy using leukocytes marked with 99m-Tc-HMPAO in Crohn's disease]. Dhôte R; Beades E; Le Dinh T; Bachmeyer C; Devaux JY; Richard B; Christoforov B Acta Gastroenterol Belg; 1995; 58(5-6):353-63. PubMed ID: 8775991 [TBL] [Abstract][Full Text] [Related]
7. 99Tcm HMPAO-labelled leucocyte imaging in Crohn's disease: a subtraction technique for the quantification of disease activity. Tindale WB; Barber DC; Giaffer MH; Senior S; Holdsworth CD Clin Phys Physiol Meas; 1992 Feb; 13(1):37-50. PubMed ID: 1563220 [TBL] [Abstract][Full Text] [Related]
8. Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease. Papós M; Nagy F; Láng J; Csernay L Eur J Nucl Med; 1993 Sep; 20(9):766-9. PubMed ID: 8223770 [TBL] [Abstract][Full Text] [Related]
9. Technetium-99m HMPAO labelled leucocyte scanning in the initial diagnosis of Crohn's disease. Bury B Br J Radiol; 1995 Apr; 68(808):437. PubMed ID: 7795986 [No Abstract] [Full Text] [Related]
10. 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Annovazzi A; Biancone L; Caviglia R; Chianelli M; Capriotti G; Mather SJ; Caprilli R; Pallone F; Scopinaro F; Signore A Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):374-82. PubMed ID: 12634965 [TBL] [Abstract][Full Text] [Related]
11. Tc HMPAO-labelled white cell scintigraphy in Cröhn's disease of the small bowel. Kennan N; Hayward M Clin Radiol; 1992 May; 45(5):331-4. PubMed ID: 1516344 [TBL] [Abstract][Full Text] [Related]
12. Different abdominal scintigraphy pattern in patients with ulcerative colitis, Crohn's disease and seronegative spondylarthropathies. Alonso JC; López-Longo FJ; Lampreave JL; González CM; González M; Almoguera I; Carreño L Br J Rheumatol; 1995 Oct; 34(10):946-50. PubMed ID: 7582701 [TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods. Mansfield JC; Giaffer MH; Tindale WB; Holdsworth CD Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945 [TBL] [Abstract][Full Text] [Related]